Quantcast

Latest Valvular heart disease Stories

2014-09-17 08:29:17

Third Multi-Center Study Shows Compelling Results Consistent with Previous Trials; Data Presented at TCT KIRKLAND, Wash., Sept. 17, 2014 /PRNewswire/ -- Cardiac Dimensions(®), Inc. today announced that new long-term outcomes data from the TITAN II clinical trial of its enhanced CARILLON Mitral Contour System showed significant and sustained improvements in mitral regurgitation, functional improvement, quality of life and reverse cardiac remodeling. The long-term safety and efficacy data,...

2014-09-15 16:28:52

No Cases of Moderate or Severe Paravalvular Aortic Regurgitation at One Year MARLBOROUGH, Mass., Sept. 15, 2014 /PRNewswire/ -- New data from the Boston Scientific (NYSE: BSX) clinical trial program of the Lotus(TM) Valve System continue to demonstrate strong performance as a less invasive treatment for patients with severe aortic stenosis who are considered high risk for surgical valve replacement. Data from the REPRISE II clinical trial confirmed safety and effectiveness out to one year,...

2014-09-15 12:27:22

Tiara(TM) Transcatheter Mitral Valve program featured in multiple scientific presentations NASDAQ: NVCNTSX: NVC WASHINGTON, DC, Sept. 15, 2014 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) announced today that its Reducer(TM) technology was featured in a "live case" broadcast on Sunday, September 14, 2014 at the 26th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. A Clinical update on the company's Tiara(TM)...

2014-08-25 16:26:46

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/703947/Aortic-Valve-Stenosis-Global-Clinical-Trials-Review-H2-2014.htmlAortic Valve Stenosis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014" provides data on the Aortic Valve Stenosis clinical trial...

heart
2014-08-14 02:00:48

DETROIT, Aug. 13, 2014 /PRNewswire/ -- For the first time in the United States, doctors at Henry Ford Hospital used a minimally invasive procedure to replace a failing, hard-to-reach heart valve with a new one - and placed it just outside the heart. Due to prior medical procedures, the metro Detroit woman was not a candidate for traditional open heart surgery to replace her failing tricuspid valve. One major U.S. medical center turned her down for treatment. Doctors at another said her...

2014-08-12 12:27:43

- Medicare will Provide National Coverage for People with Severe Degenerative Mitral Regurgitation Deemed Too Sick for Surgery ABBOTT PARK, Ill., Aug. 12, 2014 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) recently issued a National Coverage Determination (NCD) that extends coverage for Medicare beneficiaries in the United States to Transcatheter Mitral Valve Repair with Abbott's (NYSE: ABT) MitraClip(® )System. The MitraClip System is a...

2014-08-07 23:11:05

HeartStitch, Inc. receives landmark patent "Suturing Devices and Methods for Suturing an Anatomic Valve" FOUNTAIN VALLEY, CA – (PRWEB) August 07, 2014 -- By: HeartStitch Prof. Anthony Nobles, CEO of HeartStitch HeartStitch, Inc. today announced that it has received another US Patent for its HeartStitch Technology. The patent “Suturing devices and methods for suturing an anatomic valve” is for the HeartStitch MR and AP products that are designed to allow physicians to be...

2014-08-07 16:27:55

Valve Clinic Team is first locally to use device for Mitral Valve Regurgitation CLEARWATER, Fla., Aug. 7, 2014 /PRNewswire-USNewswire/ -- Morton Plant Hospital continues to offer the latest treatments in cardiac care, particularly for individuals with heart valve problems who may not be able to have traditional open heart surgery. Morton Plant is among the first hospitals in Florida and the first locally to use the new MitraClip device for people with severe mitral valve regurgitation....

2014-07-31 17:32:49

Oxford University Press Data taken from the German Aortic Valve Registry and published in the European Journal of Cardio-Thoracic Surgery A survey, published online in the European Journal of Cardio-Thoracic Surgery, of 13,860 patients who had undergone interventions for aortic valve disease in Germany has revealed that over 80% were in the same or a better state of health one year after the intervention, and was satisfied with the procedural outcome. Aortic stenosis – the...

2014-07-29 23:04:40

Global Cardiac Surgery devices market growth will be driven by extensive technological advancements, especially for transcatheter heart valve devices, reports iData Research Vancouver, BC (PRWEB) July 29, 2014 According to a new report series by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the Global Cardiac Surgery Devices Market will grow to over $8 billion by 2018. This growth will be fueled by extensive technological...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related